0001708599 2026-05-22 2026-05-22 0001708599 1 2026-05-22 2026-05-22 iso4217:USD pure shares S-3 S-3 EX-FILING FEES 0001708599 Serina Therapeutics, Inc. N/A N/A S-3 Serina Therapeutics, Inc. false Equity Common stock, par value $0.0001 true 16450442 1.57 25827193.94 0.0001381 3566.74 25827193.94 3566.74 0.00 0.00 3566.74 Pursuant to Rule 416(a) under the Securities Act of 1933, as amended, or the Securities Act, this registration statement shall also cover any additional common units that become issuable by reason of any unit dividend, unit split, recapitalization or other similar transaction that results in an increase in the number of the outstanding common stock of the registrant. Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(c) under the Securities Act on the basis of the average of the high and low sale prices of the common stock, par value $0.0001 ("Common Stock") on May 18, 2026, as reported on the NYSE American.